Back Home Search

Skin/Non-Melanoma

    • Protocols

    • UW24072

      OPEN TO ACCRUAL

      Phase 1 IFx-Hu2.0 + Pembrolizumab in Advanced or Metastatic Merkel Cell Carcinoma